Objective: Prior studies identified significant racial disparities as well as regional variation in outcomes of patients with peripheral artery disease (PAD). We aimed to determine whether regional variation contributes to these racial disparities.
Peripheral artery disease (PAD) afflicts millions of Americans but disproportionately affects minorities. [1] [2] [3] [4] Black patients develop PAD at higher rates compared with other racial groups, have greater comorbid burdens, and present to care later, with more severe disease. [5] [6] [7] In addition to disparities in the prevalence and presentation of PAD, differences exist in treatment and outcomes. 4, 8 Black patients with chronic limb-threatening ischemia are up to four times as likely to undergo amputation and less likely to undergo bypass surgery for limb salvage. 8, 9 Even after revascularization, they more often experience early graft failure and other major adverse limb events (MALEs), with worse amputation-free survival compared with white patients. [9] [10] [11] However, despite these disparities, a recent study by Brothers et al 12 demonstrated paradoxically higher survival in black patients undergoing lower extremity revascularization.
Although the causes of racial disparities in health outcomes are multifactorial, a wealth of evidence demonstrates that geographic and regional variation influences health care costs, utilization, treatment strategies, and outcomes. [13] [14] [15] [16] [17] [18] [19] In recent years, an increased focus on regional variation in surgical practice revealed that where a patient resides often has an impact on the patient's propensity to undergo surgery or amputation more than the actual surgical indication. 20, 21 Our prior studies showed significant variation in the treatment of various vascular conditions, including carotid artery disease and abdominal aortic aneurysms. 22, 23 Similarly, variation exists in the intensity of vascular care provided to patients in the year before major amputation, with disproportionately large numbers of black patients living in the regions with high amputation rates and low intensity of care. 6, 20, 24 We sought to use national data from the Society for Vascular Surgery Vascular Quality Initiative (VQI) to evaluate whether regional variation confounds the relationship between race and outcomes after infrainguinal revascularization and amputation.
METHODS
Subjects. We identified all black and white patients who underwent either amputation (we included only amputations above the ankle) or lower extremity revascularization (infrainguinal endovascular revascularization or open surgical bypass) for occlusive disease in the VQI between 2003 and 2017. The VQI is a cooperative quality improvement initiative developed in 2002 to improve outcomes in vascular surgery and collects data from 412 centers in 46 U.S. states and 1 Canadian province, organized into 18 deidentified regions. Vascular surgeons, data managers, trainees, and nurses enter >200 variables including demographics of patients, comorbid conditions, postoperative complications, and 1-year follow-up data. Longterm mortality is ascertained by linkage to the Social Security Death Index. We excluded three regions because of low procedural volume, defined as <100 procedures. The Beth Israel Deaconess Medical Center Institutional Review Board approved this study and waived the need for consent of the patient because of the nature of the design and minimal risk to human subjects.
Definitions and variables. We classified center volume by the average yearly volume of procedures in each center since its initiation into the VQI, excluding the lowest volume year to account for centers that entered into the VQI later in the year. After calculating adjusted average yearly volume by center, we classified centers into quintiles of volume. The VQI records demographics and comorbidities, and we further defined chronic kidney disease (stage 3 or higher) as a glomerular filtration rate <60 mL/min/1.73 m 2 by the Chronic Kidney Disease Epidemiology Collaboration formula.
Outcomes. Our primary outcome was risk-adjusted mortality at 30 days postoperatively and long term in all patients. Secondary outcomes included risk-adjusted rates of amputation and MALE (defined as ipsilateral reintervention or ipsilateral amputation) in those patients undergoing peripheral vascular intervention or infrainguinal revascularization. Only major amputations (defined as proximal to the ankle joint) were considered. For patients who underwent amputation, we considered MALE as any subsequent intervention on the side of the amputation or conversion to more proximal amputation.
Statistical analysis. We compared baseline characteristics between black and white patients using the c 2 test, Fisher exact test, t-test, and Wilcoxon rank sum test where appropriate. To calculate risk-adjusted rates of the 30-day outcomes, we constructed hierarchical linear regression models clustering at the center level and used these to compute the marginal effects of black compared with white race, the marginal effects of a patient's region, and the interaction between race and region. For long-term outcomes, we constructed Kaplan-Meier curves and performed multivariable Cox regression, similarly clustering at the center level. To compare between-group differences across regions, we constructed individual Cox models comparing outcomes between black and white patients in each region. To compare within-group outcomes, we constructed separate Cox models in black patients and white patients. We randomly selected region 3 as the referent group. The resultant hazard ratios (HRs) were compared using forest plots. We controlled for age, race, sex, surgery year, procedure type, coronary artery disease, hypertension, prior peripheral interventions, cerebrovascular disease, congestive heart failure, chronic kidney disease (defined as glomerular filtration rate <60 mL/min/1.73 m 2 ), dialysis dependence, chronic obstructive pulmonary disease, indication (asymptomatic, claudication, rest pain, tissue loss, or acute limb ischemia), Sensitivity analyses. To address issues with missing follow-up data, we performed two separate sensitivity analyses to ensure that our results were robust. First, we examined outcomes only in centers with >50% followup rates (136/223 centers [39%]). Second, we repeated our primary analysis first by assigning all black patients with missing data to having a limb event (for both amputation and MALE) and then by assigning all black patients with missing data to not having a limb event.
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RESULTS
Baseline characteristics
We identified 90,418 patients, 15,527 (17%) of whom were black. Patients underwent 31,263 bypasses, 52,462 endovascular interventions, and 6693 amputations. Black patients were younger and less likely to smoke, to have coronary artery disease, and to have chronic obstructive pulmonary disease, but they were more likely to have diabetes, limb-threatening ischemia, dialysis dependence, and hypertension and to be self-insured or on Medicaid (Table) . The proportion of black patients undergoing treatment in centers in the lowest two quintiles of volume ranged from 0% to 100% across regions, with black patients more likely than white patients to undergo treatment at low-volume centers in 8 of 15 regions. Similarly, rates of black patients on Medicaid or uninsured varied from 6% to 22% and exceeded the rates of white patients in every region.
Risk-adjusted 30-day outcomes
Racial disparities across regions (between-group variation). Adjusted 30-day mortality ranged from 1.16% to 2.08% for white patients and 0% to 3.02% for black patients (Fig 1) . In five regions, black patients experienced significantly lower rates of 30-day mortality than white patients did in those regions (all P < .05). The adjusted 30-day rates of MALE varied from 4.04% to 8.33% in white patients and 2.40% to 8.14% in black patients (Fig 2) . Black patients experienced similar rates of MALE as white patients in all regions (all P > .05; Fig 2) . Adjusted 30-day amputation rates varied from 0.33% to 1.15% for white patients and 0% to 2.10% for black patients (Fig 3) . Black patients experienced lower 30-day amputation rates than white patients in two regions and a higher rate in one region (all P < .05).
Regional variation within racial groups. Black patients. In three regions, black patients experienced significantly different rates of adjusted 30-day mortality than black patients in other regions (both higher and lower; Fig 1) . In one region, black patients experienced significantly lower adjusted amputation rates than black patients in other regions (P < .01; Fig 3) . However, black patients experienced similar adjusted rates of MALE compared with other black patients, irrespective of region (Fig 2) . White patients. White patients in three regions similarly experienced significantly different rates of adjusted 30-day mortality than white patients in other regions (Fig 1) . Similarly, white patients in two regions experienced significantly lower adjusted rates of MALE than white patients in other regions, and adjusted amputation rates were lower in two other regions (all P < .05; Figs 2 and 3) .
Risk-adjusted long-term outcomes
Racial disparities across regions (between-group variation). Black patients experienced consistently lower adjusted long-term mortality than white patients (overall HR, 0.80; 95% confidence interval [CI], 0.73-0.88; P < .001), with no regional variation in this disparity 30-day mortality by region in black and white patients. * P < .05 for black patients compared with white patients. þ P < .05 for white patients in that region compared with white patients in other regions.
x P < .05 for black patients in that region compared with black patients in other regions.
Fig 2.
Adjusted 30-day rates of major adverse limb event (MALE) by region in black and white patients. * P < .05 for black patients compared with white patients. þ P < .05 for white patients in that region compared with white patients in other regions. x P < .05 for black patients in that region compared with black patients in other regions. (Fig 4) . This lower mortality in black patients was consistent across all procedure types (P ¼ .48). Black patients experienced consistently higher adjusted rates of MALE than white patients did (overall HR, 1.15; 95% CI, 1.06-1.25; P < .001), with no regional variation (Fig 5) . Similar to survival, this disparity was consistent in all procedure types (P ¼ .59). We found consistently higher adjusted amputation rates in black patients compared with white patients, with no regional variation (overall HR, 1.33; 95% CI, 1.18-1.51; P < .001; Fig 6) . Although consistently higher in black patients, the magnitude of the disparity in amputation rates was greater after leg bypass (HR, 1.45; 95% CI, 1.26-1.66; P < .01) than after endovascular interventions (HR, 1.08; 95% CI, 0.91-1.27; P ¼ .37), P < .01 for the comparison across procedure types.
Regional variation within racial groups. Black patients. Although the disparity in adjusted overall mortality between black and white patients did not vary across regions, the mortality rates within the two racial groups varied substantially across the regions. In black patients, three regions demonstrated significantly higher adjusted mortality rates than the other regions (HR, 1.46-1.70 using region 3 as a reference; P < .01). Similarly, two regions demonstrated significantly lower adjusted rates of MALE than the others (HR, 0.28-0.74 using region 3 as a reference; P < .05). One region exhibited significantly lower adjusted amputation rates (HR, 0.34 using region 3 as a reference [0.13-0.86]; P ¼ .02), and three regions exhibited significantly higher adjusted amputation rates (HR, 1.56-1.63; P < .01).
White patients. In white patients, adjusted mortality rates in nine regions were significantly higher than in the other regions (HR, 1.25-1.94 using region 3 as a reference; P < .05). Three regions demonstrated lower adjusted amputation rates than the other regions (HR, 0.60-0.79 using region 3 as a reference; P < .05). In contrast to survival and amputation rates, there was no difference in adjusted rates of MALE across regions.
Missing data. The VQI records data at each follow-up visit around 1 year postoperatively. Overall, 68% of patients presented for follow-up or died. Black patients returned at lower rates than white patients (61% vs 69%; P < .001). In an attempt to control for these missing data on amputation and MALE rates, we performed sensitivity analyses excluding centers with <50% follow-up rates. We found no significant difference in the adjusted rates of mortality, MALE, or amputation in this modified data set compared with our full analysis. We also performed sensitivity analyses in which we assigned all black patients with missing data to either having an event or not having an event. Our results were robust, as there was no significant difference in event rates with either change. When all black patients with missing data were assigned to be event free, black patients still experienced higher adjusted rates of MALE (HR, 1.15; 95% CI, 1.06-1.25; P < .01) and amputation (HR, 1.28; 95% CI, 1.14-1.45; P < .01). When all black patients with missing data were assigned to have an event, black patients experienced even higher adjusted rates of MALE (HR, 1.21; 95% CI, 1.12-1.32; P < .01) and amputation (HR, 1.92; 95% CI, 1.72-2.16; P < .01).
DISCUSSION
Our study demonstrates substantial regional variation in outcomes between black and white patients with PAD, both between and within racial groups. These differences in short-term outcomes likely reflect the effect of differences in local factors, such as access to care, insurance status, and treatment at high-volume centers, all of which varied significantly across regions.
In contrast, despite significant differences in long-term outcomes between black and white patients, regional variation did not contribute significantly to these disparities. We demonstrated regional variation in long-term outcomes within racial groups (ie, white patients in one region experience different rates of outcomes than white patients in another region, and the same for black patients) but found no significant regional variation in long-term outcomes between black and white patients across regions. Rates of survival in black patients, but also MALE and amputation, were consistently higher than in white patients across all regions.
This work builds on a broad foundation of previous literature that established both the racial disparities experienced by patients with PAD and the regional variation in surgical outcomes. Several prior studies revealed that black patients experience disproportionately higher amputation rates, in terms of both primary amputation and secondary amputation, and similarly higher rates of limb events. 1, 4, 6, [8] [9] [10] [24] [25] [26] Paradoxically, however, two prior studies demonstrated higher survival in black patients. 12, 27 Our study confirms these findings in a large, robust clinical registry and provides several potential explanations. Black patients were significantly younger, were more likely to be female, and were more likely to be diabetic and less likely to have vascular disease in other territories. This difference in the distribution of the comorbidities may explain the apparent survival paradox as a young, female patient with a diabetic foot ulcer is likely to live longer than an older male smoker with dry gangrene. Thus, although race, insurance status, and access to care may affect survival as well and certainly affect rate of amputation and MALE, age, sex, and diabetes status may influence survival slightly more. We attempted to control for these comorbidities using multivariable methods, but residual confounding likely remains. A similar wealth of prior works validated the influence of regional and geographic factors on surgical decisionmaking, costs, and outcomes. Birkmeyer and Dimick and colleagues published widely on the topic of regional variation in a variety of surgical disciplines, including general, bariatric, thoracic, and high-risk surgery. [13] [14] [15] [16] 18 More recently, our group confirmed the presence of regional variation in vascular surgery as well, from carotid disease and PAD to abdominal aortic aneurysms. 6, 22, 23, 28 Regional variation is an important theme in modern surgical practice as it represents a potentially modifiable factor to improve outcomes. Initiatives such as the VQI, which provides feedback to its members as to how their results compare with those of other regions and centers, enable quality improvement efforts to improve outcomes in underperforming regions by adopting best practices from high-quality institutions. Our work, combined with prior research in the area, identifies several potential targets for improvement. Black patients in this study were more likely to be on Medicaid or uninsured/self-pay and were more likely to undergo care at a low-volume center. Eslami et al 29 demonstrated
that nonwhite, low-income patients without commercial insurance were more likely to undergo amputation. Similarly, Goodney et al 20 found that patients in regions with the highest amputation rates were more likely to be black and diabetic. Most strikingly, Dimick and coworkers showed that although black patients were more likely to live near a high-quality hospital, they were more likely to undergo care at low-quality hospitals.
Efforts to address these disparities should center on identifying vulnerable populations and high-risk patients who would benefit from treatment at high-volume, highquality hospitals. This study must be interpreted in the context of its design. Although we know the primary insurer of most of the patients in our study, we lacked insurance information on 20% of patients. In addition, we know only the primary insurer and do not capture secondary insurance and, most notably, cannot identify patients with both Medicare and Medicaid eligibility. Numerous works, including a white paper from the Centers for Medicare and Medicaid Services, show this to be a vulnerable, high-risk population. [30] [31] [32] [33] [34] The VQI also records only deidentified regions but not ZIP codes or other, more specific markers of socioeconomic status, so we are unable to fully control for those factors in our models. In addition, with more than a third of our patients lost to follow-up, we are likely to have missed some limb events (mortality is captured more robustly through linkage to the Social Security Death Index). Indeed, as black patients were less likely to present in follow-up, they likely experience even higher rates of amputation and limb events relative to white patients. Our sensitivity analysis reveals that amputation rates could be as high as almost double the rates experienced by white patients.
CONCLUSIONS
Significant racial disparities exist in outcomes after lower extremity procedures in patients with PAD, with regional variation contributing to perioperative but not long-term outcome disparities. Underperforming regions should use these data to generate quality improvement projects, as understanding the etiology of these disparities is critical to improving the care of all patients with PAD. 
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